<DOC>
	<DOC>NCT00947102</DOC>
	<brief_summary>Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.</brief_summary>
	<brief_title>Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>ECOG performance status 02 at the time of inclusion Following R0 or R1 pancreatic tubular adenocarcinoma resection Pregnancy Serious comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>pancreatic tubular adenocarcinoma</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>gene expression</keyword>
	<keyword>immunological status</keyword>
	<keyword>serological status</keyword>
	<keyword>pancreatic tubular adenocarcinoma adjuvant setting</keyword>
</DOC>